These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 10824464

  • 1. Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India.
    Saha MK, Chakrabarti S, Panda S, Naik TN, Manna B, Chatterjee A, Detels R, Bhattacharya SK.
    Indian J Med Res; 2000 Feb; 111():37-9. PubMed ID: 10824464
    [Abstract] [Full Text] [Related]

  • 2. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS, Brajachand N, Singh HL, Singh YM.
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [Abstract] [Full Text] [Related]

  • 3. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS, Singh NB, Singh HL, Singh YM.
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, Carbonara S, Monarca R, Quercia G, Florenzano G, Novati S, Sardu A, Iovinella V, Casti A, Romano A, Uccella I, Maida I, Brunetti B, Mura MS, Andreoni M, Rezza G.
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [Abstract] [Full Text] [Related]

  • 8. Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy.
    Camoni L, Regine V, Salfa MC, Nicoletti G, Canuzzi P, Magliocchetti N, Rezza G, Suligoi B, SerT Study Group.
    Ann Ist Super Sanita; 2010 Jul; 46(1):59-65. PubMed ID: 20348620
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S.
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I.
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
    Badridze N, Chkhartishvili N, Abutidze A, Gatserelia L, Sharvadze L.
    Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: a cross-sectional study.
    Camoni L, Regine V, Salfa MC, Nicoletti G, Canuzzi P, Magliocchetti N, Rezza G, Suligoi B, Sert Study Group.
    Scand J Infect Dis; 2009 Dec; 41(6-7):520-3. PubMed ID: 19415569
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T, Ahmed T, Iqbal A, Islam M, Islam MN.
    J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
    [Abstract] [Full Text] [Related]

  • 16. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
    Imani R, Karimi A, Rouzbahani R, Rouzbahani A.
    East Mediterr Health J; 2008 Dec; 14(5):1136-41. PubMed ID: 19161086
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
    Sungkanuparph S, Vibhagool A, Manosuthi W, Kiertiburanakul S, Atamasirikul K, Aumkhyan A, Thakkinstian A.
    J Med Assoc Thai; 2004 Nov; 87(11):1349-54. PubMed ID: 15825712
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran.
    SeyedAlinaghi S, Jam S, Mehrkhani F, Fattahi F, Sabzvari D, Kourorian Z, Jabbari H, Mohraz M.
    Acta Med Iran; 2011 Nov; 49(4):252-7. PubMed ID: 21713737
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
    Zamani S, Radfar R, Nematollahi P, Fadaie R, Meshkati M, Mortazavi S, Sedaghat A, Ono-Kihara M, Kihara M.
    Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578
    [Abstract] [Full Text] [Related]

  • 20. High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina.
    Weissenbacher M, Rossi D, Radulich G, Sosa-Estáni S, Vila M, Vivas E, Avila MM, Cuchi P, Rey J, Peralta LM.
    Clin Infect Dis; 2003 Dec 15; 37 Suppl 5():S348-52. PubMed ID: 14648445
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.